Serum ceruloplasmin and copper levels in patients with primary brain tumors
Klinische Wochenschrift · 1984-02 · 62 (4) · 187-189
DOI: 10.1007/bf01731643 ↗Kurz gefasst
Fachartikel in der Zeitschrift Klinische Wochenschrift, 1984-02. Verfasst von L Turecký und 4 weiteren Autor:innen. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
Serum copper and ceruloplasmin levels are known to increase in several malignancies such as osteosarcomas, some gastrointestinal tumors, and lung cancer. In this study serum copper and ceruloplasmin levels in 40 patients with primary brain tumors were studied. Both parameters were increased in sera of patients with tumors in comparison with healthy subjects or patients with non-tumorous neurological diseases. It is concluded that copper and ceruloplasmin represent a good complement to some other nonspecific parameters in evaluating the activity of malignancy and the therapeutic results.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Turecký, L., Kalina, P., Uhlíková, E., Námerová, S., & Krizko, J. (1984). Serum ceruloplasmin and copper levels in patients with primary brain tumors. Klinische Wochenschrift, 62(4), 187-189. https://doi.org/10.1007/bf01731643
Vancouver
Turecký L, Kalina P, Uhlíková E, Námerová S, Krizko J. Serum ceruloplasmin and copper levels in patients with primary brain tumors. Klinische Wochenschrift. 1984;62(4):187-189. doi:10.1007/bf01731643
BibTeX
@article{Tureck1984,
author = {Turecký, L and Kalina, P and Uhlíková, E and Námerová, S and Krizko, J},
title = {Serum ceruloplasmin and copper levels in patients with primary brain tumors},
journal = {Klinische Wochenschrift},
year = {1984},
volume = {62},
number = {4},
pages = {187--189},
doi = {10.1007/bf01731643}
}
EUVIMED